Posted in News
MONOPOLY BRANDED GENERICS
Ethosuximide 250mg/5ml has changed from Category C to Category A in the July 2017 edition of the England & Wales Drug Tariff. The price per DDD increased from less than £0.30 in February 2017 to over £15.00 in October 2017. This item has been added to the Monopoly Generics Tag in Define.
Following the expiry of the patent for pregabalin in October 2016, cheaper brands have become available. In August, the availability of cheaper products was recognised in the England & Wales Drug Tariff. The products have moved from Category C (not readily available as a generic) to Category M (widely available) and a typical example of the change is that the price of 84 pregabalin 100mg capsules has fallen from £96.60 in July to £2.98 in August. Trusts may wish to review their use of branded pregabalin.